Telomerase assay and HPV 16/18 typing as adjunct to conventional cytological cervical cancer screening

Tumor Biology

Volumn 23, Issue 2, 2002, Pages 87-92

  Ngan, Hextan Y S ^a,b   Cheung, Annie N Y ^a   Liu, Stephanie S ^a   Liu, Ka Lai ^a   Tsao, Sai Wah ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Cervical cytology; Cervical intraepithelial neoplasia; High grade squamous intraepithelial lesions; Low grade squamous intraepithelial lesions; Telomerase Repeat Amplification Protocol

Indexed keywords

TELOMERASE;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER SCREENING; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION; VIRUS TYPING; WART VIRUS;

EID: 0036273196     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000059710     Document Type: Article

References (28)

1. Structure and function of telomeres
2. Structure and function of telomerase
3. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity
4. Telomerase activity in gynecologic tumors
5. Telomerase activity in gynecological tumors
6. Telomerase activity and expression of its RNA component in cervical lesions
7. Abnormal expression and mutation of p53 in cervical cancer - A study at protein, RNA and DNA levels
8. Human papillomavirus testing in primary cervical screening
9. Human papillomavirus and cervical intraepithelial neoplasia grade II-III: A population-based case-control study
10. Telomerase activation by the E6 gene product of human papillomvirus type 16
11. Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease
12. Meta-analysis of Pap test accuracy
13. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses: Developed and approved at the National Cancer Institute Workshop, Bethesda 1988
14. Clinical significance of telomerase activation and telomeric restriction fragment (TRF) in cervical cancer
15. Telomerase activation in cervical cancer
16. Telomerase expression in normal epithelium, reactive atypia, squamous dysplasia, and squamous cell carcinoma of the uterine cervix
17. Application of telomerase assay for the screening of cervical lesions
18. Differential expression of telomerase activity in human cervical cancer and cervical intraepithelial neoplasia lesions
19. Telomerase activity and human papillomavirus in malignant, premalignant and benign cervical lesions
20. Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions
21. Telomerase activity in cervical cancer is quantitatively distinct from that in its precursor lesions
22. Telomerase activity in Papanicolaou smear-negative exfoliated cervical cells and its association with lesions and oncogenic human papillomaviruses
23. Telomerase, p53 and human papillomavirus infection in the uterine cervix
24. Telomerase expression in normal endometrium, enodmetrial hyperplasia, and endometrial adenocarcinoma
25. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells
26. Cervical intraepithelial neoplasia
27. Human papillomavirus status in the prediction of high-grade cervical intraepithelial neoplasia in patients with persistent low-grade cervical cytological abnormalities
28. Does typing of human papillomavirus assist in the triage of women with repeated low-grade, cervical cytologic abnormalities?